Last update July 3, 2022

102 Plus™

High Risk

Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.

102 Plus is a tradename that contains several active ingredients in its composition:

  • Ginkgo. Ginkgo biloba ( Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.)
  • Ginseng (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
  • Guarana (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
  • Iron Salts ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Magnesium Oxide ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Riboflavin ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Selenium (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
  • Vitamin B1 Substances ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Vitamin B12 Substances ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Vitamin B6 ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Vitamin C ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Vitamin E ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Zinc Salts ( Safe. Compatible. Minimal risk for breastfeeding and infant.)

Since each active ingredient of this product may have a different level of risk for breastfeeding, we establish that of the product with higher risk.

For more information (pharmacokinetics, references, ...) tap each active ingredient.

Note: The composition of certain tradenames varies in each country. Please, make sure this is the composition of the tradename you are looking for..

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Total visits

4,235

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM